FILE PHOTO: A view shows testing tubes in Hadassah clinic, which offers tests for for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
(Reuters) - With much of the world living in lockdown, the spread of the new coronavirus, SARS-CoV-2, that was first detected in China late last year is beginning to slow in some places. As of April 23, 2.7 million had been infected and 192,000 killed by COVID-19, the disease caused by the virus.
While a safe, effective vaccine is still more than a year away, researchers are rushing to repurpose existing drugs and non-drug therapies as well as testing promising experimental drugs that were already in clinical trials.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
